Hyperfine, Inc.

NASDAQ:HYPR

Medical - Devices

Healthcare
$0.56 +15.65%

+$0.22 today

Market cap
$51.10M
Beta
1.38
P/E (TTM)
-4.5
EPS (TTM)
-$0.36
52W Low $0.66High $2.22

Volume 1.16M

Average 0.60M

HYPR Total Debt

Short-term and long-term borrowings combined.

Hyperfine, Inc.NASDAQ: HYPR

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt rises 4976.8% from a year ago

Total debt stood at $13.35M at the end of Q1 FY2026, up 4976.8% from a year earlier and up 4152.2% from the prior quarter.

Context

  • Total debt amounted to 22.1% of total assets at the end of Q1 FY2026, up 21.6 pp from a year earlier.
  • Total debt increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps rising in the next quarterly balance sheet after a +4976.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$13.35M+4152.2% QoQ
Last fiscal yearDec 2025
$314K+16.7% YoY
Year agoMar 2025
$263K+4976.8% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4976.8%——
1 year+16.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
314K USD
Year-over-year change
+16.7%

Total Debt vs competitors

How HYPR compares with its peers on the latest reported figures

  • HYPR's Mar 2026 total debt of $13.35M is the 4th highest of the 7 companies compared; the peer median is $13.21M.
  • Its year-over-year change of +4976.8% is the highest of 7, against a peer median of -1.8%.
  • Total debt amounts to 22.1% of total assets for HYPR, versus a peer median of 11.8%.
HYPR Competitors Peer median
Total Debt for HYPR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
LUNGPulmonx CorporationMar 2026$56.29M -1.2%+32.2%46.9%
FONRFONAR CorporationMar 2026$38.83M -2.4%+0.6%17.7%
VANIVivani Medical, Inc.Mar 2026$18.28M -3.5%+170.3%43.1%
HYPRHyperfine, Inc.Mar 2026$13.35M +4976.8%—22.1%
IMAImageneBio IncMar 2026$8.15M +23.2%+20.6%6.0%
RCELAVITA Medical, Inc.Mar 2026$1.98M -95.5%+268.8%3.8%
CNTBConnect Biopharma Holdings LimitedDec 2025$690K +287.6%+17.0%1.2%
Peer median (excluding HYPR) $13.21M-1.8%+26.4%11.8%

Competitors are the stored peer set for HYPR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents188.5M118.24M75.18M37.65M35.09M
Short-term Investments00000
Net Receivables644K3.13M4.13M8.31M6.52M
Inventory4.31M4.62M6.58M5.83M7.09M
Other Current Assets2.87M2.67M3.01M1.93M2.21M
Total Current Assets197.49M128.66M88.91M53.71M50.91M
Property, Plant & Equipment (Net)3.75M3.25M3M3.12M2.55M
Goodwill00000
Intangible Assets00000
Long-term Investments0744K0825K734K
Tax Assets00000
Other Non-current Assets1.24M1.4M2.29M1.24M1.07M
Total Non-current Assets4.99M5.39M5.29M5.19M4.35M
Total Assets202.47M134.05M94.2M58.9M55.26M
Account Payables2.25M678K1.21M1.61M4.05M
Short-term Debt00000
Tax Payables00000
Deferred Revenue730K1.38M2.07M1.49M2.5M
Other Current Liabilities700K2.2M2.91M473K1.7M
Total Current Liabilities15.74M8.8M8.77M8.73M11.73M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)510K1.53M968K1.05M729K
Other Non-current Liabilities0064K78K1.73M
Total Non-current Liabilities510K1.53M1.03M1.13M2.53M
Total Liabilities16.25M10.33M9.8M9.86M14.26M
Common Stock7K7K7K7K10K
Retained Earnings(136.32M)(209.48M)(253.72M)(294.44M)(330.02M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity186.23M123.72M84.4M49.04M41.01M
Total Debt00185K269K314K
Net Debt(188.5M)(118.24M)(75M)(37.38M)(34.77M)

Hyperfine, Inc.

NASDAQ:HYPR

Intrinsic Alpha fair value

Locked

Current Price

$0.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.